We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock
YTEN

Delisted

YTEN was delisted on the 15th of May, 2024.

Back to rankings

10 hedge funds and large institutions have $1.34M invested in Yield10 Bioscience, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more capital invested

Capital invested by funds: $798K → $1.34M (+$541K)

9% less funds holding

Funds holding: 11 → 10 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GWM
Grand Wealth Management
Michigan
+$85.5K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$10.3K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$20.9K
2
Millennium Management
Millennium Management
New York
-$20K
3
TRCT
Tower Research Capital (TRC)
New York
-$9.15K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$1.09K
5
Bank of America
Bank of America
North Carolina
-$14
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Cannell & Co
New York
$714K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$295K +$10.3K +142 +3%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$96.2K -$1.09K -15 -1%
BlackRock
4
BlackRock
New York
$86.6K – – –
GWM
5
Grand Wealth Management
Michigan
$78.1K +$85.5K +1,178 New
BC
6
Birchview Capital
Vermont
$52K – – –
CWP
7
Concord Wealth Partners
Virginia
$9.66K – – –
TRCT
8
Tower Research Capital (TRC)
New York
$7K -$9.15K -126 -53%
IA
9
IFP Advisors
Florida
$188 – – –
Wells Fargo
10
Wells Fargo
California
$77 – – –
TWA
11
TCI Wealth Advisors
Arizona
$9 – – –
Morgan Stanley
12
Morgan Stanley
New York
$3 – – –
SIC
13
Salem Investment Counselors
North Carolina
$3 – – –
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
– -$20.9K -528 Closed
Millennium Management
15
Millennium Management
New York
– -$20K -498 Closed
Bank of America
16
Bank of America
North Carolina
– -$14 – –
UBS Group
17
UBS Group
Switzerland
– -$10 – –

YTEN Hedge Fund Activity: Q1 2023 in Review

10 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q1 2023, worth a combined $1.34M — up 68% from $798K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of YTEN and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Grand Wealth Management, opening a new position worth an estimated $85.5K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $20.9K sold.

  • 10 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q1 2023, down from 11 in Q4 2022.
  • Funds reported $1.34M of Yield10 Bioscience, Inc. Common Stock stock for Q1 2023, up 68% quarter-over-quarter.
  • 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q1 2023 and 2 closed out, a net change of -1 holder.
  • The largest Yield10 Bioscience, Inc. Common Stock buyer in Q1 2023 was Grand Wealth Management, an estimated $85.5K added.
  • The largest Yield10 Bioscience, Inc. Common Stock seller in Q1 2023 was Susquehanna International Group, an estimated $20.9K sold.

Based on aggregated 13F filings for Q1 2023.